Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 13, 2023Nature MedicineOpen Access

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

KHKanta HorieWashington University in St. LouisGSGemma SalvadóLund UniversityNBNicolas R. BarthélemyWashington University in St. Louis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Horie et al. (2023) studied this question.

synapsesocial.com/papers/6a82fd7a67735c513e7d58cbhttps://doi.org/10.1038/s41591-023-02443-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Validating novel tau positron emission tomography tracer <scp>[F‐18]‐AV‐1451 (T807)</scp> on postmortem brain tissue2015 · 636 citations
  2. 2Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease2022 · 264 citations
  3. 3Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition2016 · 43 citations
  4. 4Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease2020 · 386 citations
  5. 5Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels2022 · 55 citations